Global Allergic Rhinitis Drugs Market Analysis & Forecasts to 2024, With the Market Value Expected to Grow at a CAGR of 3.8% - ResearchAndMarkets.com

DUBLIN--()--The "Allergic Rhinitis Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global allergic rhinitis drugs market to grow with a CAGR of 3.8% over the forecast period of 2018-2024.

Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous substance that causes an allergic reaction. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients.

The market is expected to grow due to variety of drugs and nasal sprays are developed by manufacturers for the treatment of allergic rhinitis in the coming years. According to the American Academy of Allergy, Asthma, and Immunology (AAAAI) estimates at least 50 million people in the US are affected by nasal allergies from which 30% of adults and 40% of children, in 2015.

Among the regions, North America is expected to be the largest market for allergic rhinitis. High incidences of allergic rhinitis in regions like the US, Canada, and other part of North America. In 2017, Catalent Pharma Solutions Limited received approval for Odactra drug, from the U.S. Food and Drug Administration (FDA), the first allergen extract to be administered under the tongue (sublingually), to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), for people aged between18 and 65 years. Pediapharm Inc. launched an advanced allergy medication - Rupall, in a tablet and oral form, in 2017, which is a first prescription antihistamine with three indications namely, symptoms associated with seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), and chronic spontaneous urticaria (CSU), for children and adults aged 2 years and above suffering from the allergy.

Companies Mentioned

  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Alcon
  • Adamis Pharmaceuticals
  • Belcher Pharmaceuticals
  • Dr Reddy's Laboratories
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Pfizer

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Allergic Rhinitis Drugs Market Overview

4. Global Allergic Rhinitis Drugs Market by Class of Drugs

5. Global Allergic Rhinitis Drugs Market by Route of Administration

6. Global Allergic Rhinitis Drugs Market by Region 2017-2023

7. Company Covered

For more information about this report visit https://www.researchandmarkets.com/research/l6bg48/global_allergic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs